Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adderall-XR Versus Concerta For Cancer Treatment-Related Neurocognitive Sequelae And Depression In Pediatric Patients: A Randomized Phase II Study

NCT00069927 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT00069927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00069927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adderall-XR Versus Concerta For Cancer Treatment-Related Neurocognitive Sequelae And Depression In Pediatric Patients: A Randomized Phase II Study
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2003
Completion date
September 30, 2006
Enrollment
12 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

depression, neurotoxicity, unspecified childhood solid tumor, protocol specific